Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer

Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer
复制标题

通过致癌 KRAS 激活抑制 MicroRNA 200 家族表达可促进 KRAS 驱动的癌症中的细胞存活和上皮间质转化

DOI:
10.1128/mcb.00079-16
复制
发表时间:
2016-08
影响因子:
5.3
通讯作者:
Lin Zhang
Lin Zhang
中科院分区:
生物学2区
文献类型:
--
作者:
Xinhong He;Janos L. Tanyi;Feng Yang;Lin Zhang

文献摘要

参考文献

相似文献

摘要致癌的KRAS在肺癌、结肠癌、胰腺癌和黑色素瘤等多种人类癌症的恶性转化、抗细胞凋亡和转移中起重要作用。MicroRNAs(MiRNAs)是一种内源性的18-25个核苷酸的非编码小RNA,通过降解靶mRNAs或抑制蛋白质翻译,以序列特异性的方式调节基因的表达。在本研究中,通过在表达致癌KRAS的IMR90和MCF10A细胞中进行基于阵列的miRNA分析,我们发现microRNA200(mir-200)家族的表达受到KRAS激活的抑制,并且这种抑制除了ZEB1外还受到转录因子Jun和SP1的介导。恢复mir-200的表达可抑制KRAS诱导的体外细胞转化和体内肿瘤形成。此外,我们还发现,通过直接靶向抗凋亡基因BCL2,mir-200的增强表达可以消除KRAS诱导的细胞凋亡抵抗。最后,mir-200能够拮抗突变KRAS驱动的上皮-间充质转化(EMT)。总之,我们的结果表明,抑制内源性mir-200的表达是肿瘤发生和发展过程中对KRAS激活的重要细胞反应之一。
ABSTRACT Oncogenic KRAS contributes to malignant transformation, antiapoptosis, and metastasis in multiple human cancers, such as lung, colon, and pancreatic cancers and melanoma. MicroRNAs (miRNAs) are endogenous 18- to 25-nucleotide noncoding small RNAs that regulate gene expression in a sequence-specific manner via the degradation of target mRNAs or inhibition of protein translation. In the present study, using array-based miRNA profiling in IMR90 and MCF10A cells expressing oncogenic KRAS, we identified that the expression of the microRNA 200 (mir-200) family was suppressed by KRAS activation and that this suppression was mediated by the transcription factors JUN and SP1 in addition to ZEB1. Restoration of mir-200 expression compromised KRAS-induced cellular transformation in vitro and tumor formation in vivo. In addition, we found that enforced expression of mir-200 abrogated KRAS-induced resistance to apoptosis by directly targeting the antiapoptotic gene BCL2. Finally, mir-200 was able to antagonize the epithelial-mesenchymal transition (EMT) driven by mutant KRAS. Collectively, our results suggest that repression of endogenous mir-200 expression is one of the important cellular responses to KRAS activation during tumor initiation and progression.
DOI: 10.1126/science.1064921
发表时间: 2001-10-26
期刊: SCIENCE
影响因子: 56.9
作者:
Lagos-Quintana, M;Rauhut, R;Tuschl, T
通讯作者: Tuschl, T
DOI: --
发表时间: 1998-08
期刊: Cancer research
影响因子: 11.2
作者:
R. Fenton;J. Hixon;P. Wright;A. Brooks;T. Sayers
通讯作者: R. Fenton;J. Hixon;P. Wright;A. Brooks;T. Sayers
DOI: 10.1038/srep18652
发表时间: 2016-01-05
期刊: Scientific reports
影响因子: 4.6
作者:
Ungewiss C;Rizvi ZH;Roybal JD;Peng DH;Gold KA;Shin DH;Creighton CJ;Gibbons DL
通讯作者: Gibbons DL
DOI: 10.1074/jbc.272.39.24113
发表时间: 1997-09-26
影响因子: 4.8
作者:
Finco, TS;Westwick, JK;Baldwin, AS
通讯作者: Baldwin, AS
DOI: 10.1038/354494a0
发表时间: 1991-12-12
期刊: NATURE
影响因子: 64.8
作者:
SMEAL, T;BINETRUY, B;KARIN, M
通讯作者: KARIN, M